HomeESPR • NASDAQ
add
Esperion Therapeutics Inc
Nakaraang pagsara
$2.47
Sakop ng araw
$2.38 - $2.59
Sakop ng taon
$0.69 - $4.18
Market cap
626.62M USD
Average na Volume
4.39M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 168.45M | 143.73% |
Gastos sa pagpapatakbo | 41.43M | 12.21% |
Net na kita | 61.83M | 390.04% |
Net profit margin | 36.71 | 219.00% |
Kita sa bawat share | 0.22 | 319.12% |
EBITDA | 85.26M | 2,040.79% |
Aktuwal na % ng binabayarang buwis | 2.89% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 167.85M | 15.95% |
Kabuuang asset | 465.89M | 35.50% |
Kabuuang sagutin | 767.85M | 4.82% |
Kabuuang equity | -301.96M | — |
Natitirang share | 256.81M | — |
Presyo para makapag-book | -2.01 | — |
Return on assets | 51.35% | — |
Return on capital | 107.71% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 61.83M | 390.04% |
Cash mula sa mga operasyon | 45.24M | 229.44% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 30.16M | -13.81% |
Net change in cash | 75.40M | 171,275.00% |
Malayang cash flow | 958.12K | 102.05% |
Tungkol
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Wikipedia
Itinatag
May 1998
Website
Mga Empleyado
294
